This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Matthew William Dampier Perry: Innovator in Pharmaceutical Compounds
Introduction
Matthew William Dampier Perry is a notable inventor based in Leicestershire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Matthew holds a patent for a compound that is described as a pharmaceutically acceptable salt, wherein various groups and substituents are defined. This compound is particularly useful in the treatment or prophylaxis of autoimmune, inflammatory, proliferative, and hyperproliferative diseases. His innovative work in this area showcases his commitment to advancing medical science.
Career Highlights
Matthew is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role there has allowed him to contribute to the development of important pharmaceutical compounds that can potentially improve patient outcomes.
Collaborations
Matthew has worked alongside esteemed colleagues such as Anthony Howard Ingall and John R Bantick. Their collaborative efforts have likely enhanced the research and development processes within their projects.
Conclusion
Matthew William Dampier Perry's contributions to pharmaceutical innovations reflect his dedication to improving healthcare through science. His patent and work at AstraZeneca AB highlight the importance of collaboration and innovation in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile